Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2024-01-19 to 2025-01-18
Current total value of award: $2000000
Description: THE PRIMARY OBJECTIVE OF THIS REQUIREMENT IS TO MAKE THE RICH CLINICAL INFORMATION ENCODED BY BILLIONS OF REAL-WORLD LABORATORY TEST RESULTS AVAILABLE TO EVERYONE, FREE OF CHARGE, IN AN EFFORTLESS YET HIPAA COMPLIANT MANNER, TO ADVANCE REGULATORY SCI